European Connected Health Alliance Pop-Up: Hexoskin's CEO Presents New Ways of Keeping Chronic Cardiac and Pulmonary Diseases Patients Safe at Home during the COVID-19 Pandemic.

July 06, 2020

As countries are affected by COVID-19, populations are being asked to self-isolate and prevent the spread of the virus in Europe and Canada. For instance, patients suffering from cardiac, and lung diseases such as Chronic Obstructive Pulmonary Disease (COPD) are among the most vulnerable to infections, including the Coronavirus disease (SARS-CoV-2). However, it is well documented that social isolation among older adults is a serious public health concern due to its impacts on physical and mental health.

This European Connected Health Alliance Pop Up looks at ways that Canada and Europe can connect in areas they have collaborated previously such as healthy ageing to find common lessons and solutions. 

On Thursday, July 2nd, Hexoskin's CEO and co-founder, Pierre-Alexandre Fournier attended the Pop-Up Ecosystem “Canada and Europe Tackle COVID-19 and Isolationfrom European Connected Health Alliance. Our CEO talked about new ways of keeping chronic pulmonary and cardiac diseases patients safe at home during the COVID-19 pandemic. See minute 47:00 in the video.

(Source: ECHAlliance, 2020)


With over 85 scientific publications & validation studies published since 2012, Hexoskin is the solution of choice to generate precise physiological health data. Hexoskin’s team of experts supports researchers and investigating teams to design and manage their multi-sites studies.

Request an e-meeting with our team to discuss your needs and learn more about how Hexoskin can support remote patient-centered studies.